• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX

MAYNE PHARMA GROUP LIMITED - News & Media

2.59% ! $5.15
Market Cap $418.4M  !
Healthcare Drug Manufacturers - Specialty & Generic
Add to My Watchlist

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

Articles & Videos

Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up

Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets this week, with company value as much as -33% lower @ today down to $4.34 a share after opening Week 21 at $6.48 @ on second thoughts from Cosette.Listen to the HotCopper podcast for in-depth discussions and insights on all the...

22 May 2025 15:23 (AEST)

Mayne Pharma to pay A$33M in class action settlement on alleged US conduct

Mayne Pharma (ASX:MYX) has announced it will pay A$38M – $4.7M covered by insurance – to settle a class action brought in 2021.

02 Jul 2024 09:54 (AEST)

Mayne Pharma Group (ASX:MYX) announces on-market buyback program

Mayne Pharma (ASX:MYX) has announced an on-market share buyback program for up to 10 per cent of the company's issued capital.

10 May 2023 15:03 (AEST)

Mayne Pharma (ASX:MYX) completes sale of US retail generics business for US$90 million

Mayne Pharma (ASX:MYX) has completed the sale of its US retail generics portfolio for up to US$90 million (A$134 million).

11 Apr 2023 10:31 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.15 		Change
0.130(2.59%) 		Mkt cap ! $418.4M
Open High Low Value Volume
$5.05 $5.17 $5.05 $571.9K 111.9K

Buyers (Bids)

No. Vol. Price($)
1 5000 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.17 490 1
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
MYX (ASX) Chart

Top Stories

Haranga jumps +7% on Lincoln acquisition

Haranga Resources (ASX:HAR) has spiked in intra-day trade after closing the acquisition of the Lincoln Gold Project in California.The Lincoln Project traverses 322 hectares and covers a strike length of the Mother Lode with 5.8km between Sutter Creek and Amador City. It boasts a gold resource of ...
Ionic Rare Earths falls -7% as momentum slips on vague production update Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
ASX Market Close: Index rebounds as investors buoyant | July 30, 2025 The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.